Welcome to HUPO2017
The European Proteomics Association (EuPA) and the British Society for Proteome Research (BSPR) is absolutely delighted to welcome you to the 16th Annual World Congress of the Human Proteome Organisation which will be held in Dublin on 17-21st September 2017.
The Congress is also the 11th Annual EuPA meeting and 14th Annual BSPR Meeting.
We are looking forward to providing you with a superb environment in which to present, discuss and advance your proteomic research. The world class scientific programme will consolidate existing knowledge while at the same time increase your awareness of leading edge and forward looking advances in the field.
The congress is to be held in a state-of-the-art convention centre in the heart of Dublin a world renowned and historic city that’s vibrant, friendly and energetic. You’ll find top-class restaurants and pubs as well as fantastic shopping, sporting and leisure opportunities. Beyond Dublin you’ll able to explore an enchanting country and experience the Irish welcome from the people – rich in culture, music and dance as well as the written and spoken word. What better place to combine leading edge science with an unsurpassed personal experience. We look forward to seeing/welcoming you in 2017 for an experience of a lifetime.
Céad Míle Fáilte to HUPO2017 (‘A hundred thousand welcomes’)
Prof Stephen R Pennington
Chair of the Local Organising Team
Professor of Proteomics
University College Dublin Conway Institute
About HUPO2017 Congress
Our vision for HUPO2017 Congress on “Integrated Proteomics for Healthcare Systems” is to create a meeting that will bring together world leaders with a new generation of scientists to promote HUPO’s capabilities for advancing our knowledge of the Human Proteome and the impact this will have on our understanding of health, disease and ageing. The Congress will celebrate past achievements and present new disruptive advances in proteomics. This will be achieved by a balanced scientific programme that takes into account previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities.
The programme will include key outreach events as well as sessions devoted to each of the twelve (12) current HUPO Initiatives and to the three (3) pillars of the HPP.
In recognition of the increasing role of proteomics in medicine development and point of care testing, and the consequential impact on the biopharmaceutical industry, we will have a special focus on the application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.
The objectives of HUPO2017
• Provide an important opportunity to consolidate and record the key achievements of proteomics to date
• Embrace a forward looking perspective to deliver an inflection point – a key milestone event – in the evolution of proteomics. One that will be a lasting legacy for the field.
• Engage new constituencies with the field of proteomics to support new scientific and new business opportunities
• Elicit a quantum change in global engagement of the field with the public
• We look to you our sponsors and exhibitors playing key roles in us achieving this ambitious vision.